AU
BSX icon

Algebris (UK)’s Boston Scientific BSX Stock Holding History

Algebris (UK)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,958
Closed -$561K – 74
2026
Q1 		$561K Sell
8,958
-10,282
-53% -$823K 0.04% 67
2025
Q4 		$1.84M Buy
19,240
+1,122
+6% +$110K 0.15% 56
2025
Q3 		$1.77M Buy
+18,118
New +$1.88M 0.2% 46

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Algebris (UK)'s BSX Position: Q2 2026 in Review

Algebris (UK) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 8,958 shares — an estimated $561K sold.

Algebris (UK) first reported a position in BSX in Q3 2025 and held it in 3 quarters. The position peaked at $1.84M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Algebris (UK) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Algebris (UK) sold 8,958 Boston Scientific shares in Q2 2026, an estimated $561K.
  • Algebris (UK) first reported a position in Boston Scientific in Q3 2025 and held it in 3 quarters.
  • Algebris (UK)'s Boston Scientific position peaked at $1.84M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Algebris (UK)'s 13F filing for Q2 2026, filed 11 Aug 2026.